Evidence map›Paper›PMID 41661606›Full record

ArticleJAMA pediatrics2026

Mortality Among Youth and Young Adults With Autism Spectrum Disorder, Intellectual Disability, or Cerebral Palsy.

Kelly A Shaw, Dedria McArthur, Deborah A Bilder, Michelle M Hughes, Charles E Rose, Amanda V Bakian, Maureen S Durkin, Robert T Fitzgerald, Ellen M Howerton, Christine Ladd-Acosta and 11 more

Abstract readMulticenter Study
In one paragraph

Article in JAMA pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kelly A ShawNational Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Dedria McArthurNational Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Deborah A BilderUniversity of Utah Huntsman Mental Health Institute, Salt Lake City.
Michelle M HughesNational Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Charles E RoseNational Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Amanda V BakianUniversity of Utah Huntsman Mental Health Institute, Salt Lake City.
Maureen S DurkinUniversity of Wisconsin, Madison.
Robert T FitzgeraldWashington University in St Louis School of Medicine, St Louis, Missouri.
Ellen M HowertonJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Christine Ladd-AcostaJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Maya LopezUniversity of Arkansas for Medical Sciences, Little Rock.
Elise T PasJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Walter ZahorodnyRutgers New Jersey Medical School, Newark.
Monica DiRienzoNational Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Mary E PatrickNational Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Zachary WarrenVanderbilt University Medical Center, Nashville, Tennessee.
Anita WashingtonNational Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Allison HudsonUniversity of Arkansas for Medical Sciences, Little Rock.
Sydney PettygroveUniversity of Arizona, Tucson.
Josephine ShenoudaRutgers New Jersey Medical School, Newark.
Matthew J MaennerNational Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia.

Funding

Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
Intramural CDC HHS CC999999NICHD NIH HHS P50 HD103537
6 · The paper itself

Abstract

Importance: Autism spectrum disorder (ASD), intellectual disability (ID), and cerebral palsy (CP) are lifelong neurodevelopmental conditions accompanied by varying impairments. US mortality data for these groups are limited. Objective: To compare mortality and causes of death among a multisite cohort identified at age 8 years with ASD, ID, or CP with the general population through youth or young adulthood. Design, Setting, and Participants: Nine US sites identified 32 787 individuals who met case definitions for ASD, ID, and/or CP at age 8 years during active population-based cross-sectional surveillance conducted biennially from 2000 through 2016 by the US Centers for Disease Control and Prevention's Autism and Developmental Disabilities Monitoring (ADDM) Network. Individuals were linked to death certificates through 2021. Cases with multiple conditions (18.9%) were included in each case group. General population data from the National Vital Statistics System were matched to ADDM Network sites and years of participation. Analyses were completed in 2024. Exposure(s): ASD, ID, or CP. Main Outcomes and Measures: Death and International Classification of Diseases, 10th revision (ICD-10) International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) causes from death certificate linkage. Results: There were 145 deaths among 23 393 people with ASD, 285 deaths among 14 031 people with ID, and 123 deaths among 1612 people with CP. Increased mortality compared with the general population was seen for ASD (hazard ratio [HR], 1.35; 95% CI, 1.15-1.59), ID (HR, 4.35; 95% CI, 3.87-4.88), and CP (HR, 9.62; 95% CI, 8.06-11.48). Further stratified by sex and co-occurring ID, mortality for ASD was higher only for females with co-occurring ID (HR, 5.04; 95% CI,3.21-7.91) compared with females in the general population. The distribution of causes of death varied across groups. The most common underlying cause of death ICD-10 chapters were external causes of morbidity and mortality (V01-Y98) for the general population and ASD case group, and diseases of the nervous system (G00-G99) for CP and ID case groups. The only ICD-10 chapter hazard of death that was not elevated for ID and CP compared with the general population was external causes as underlying cause of death. Mortality from external causes was also not elevated as underlying or any cause of death for ASD. There were also notable subchapter mortality differences with important clinical and public health implications. Only 11% of those with ASD, 1% of those with ID, and 49% of those with CP had an ICD-10 code for the respective disability on their death certificate. Conclusions and Relevance: In this study, individuals with ASD, ID, or CP experienced higher mortality from a range of causes compared with the general population in youth and young adulthood. Mortality among these groups is difficult to ascertain using death certificates alone, since ICD-10 codes for these disabilities were rarely listed. These findings can inform public health and health care strategies to understand and prevent health disparities and excess mortality associated with developmental disabilities.

Indexed as

Autism Spectrum DisorderCerebral PalsyIntellectual DisabilityAdolescentCause of DeathChildCross-Sectional StudiesFemaleHumansMaleUnited StatesYoung Adult

Identifiers

PMID41661606
PMCPMC12887840

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.